About Enhancer
| Enhancer ID: | E_04782 |
| Species: | Homo sapiens |
| Position : | chr6:142706180-142706230   |
| Year: | 2019 |
| Title: | Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 30755618 |
| Tissue: | brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | Neuro-2a |
| CVCL ID: | CVCL_0470 |
| Cell Type: | neuroblastoma cell |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | RNA-seq; whole-genome sequencing |
| Low Throughput Method: | RT-RT-qPCR; Western blot |
About Target Gene
| Target gene : | ADGRG6 |
About TF
| TF name : | NA |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg19)
3 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_04767 | chr6:142706180-142706230 | urinary bladder | malignant cell | urinary bladder carcinoma |
| E_04768 | chr6:142706180-142706230 | urinary bladder | malignant cell | urinary bladder carcinoma |
| E_04781 | chr6:142706180-142706230 | umbilical vein | umbilical vein endothelial cell | NA |
Expression of Target Genes for the Enhancer